MedPath

THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial

Not Applicable
Completed
Conditions
Critical Aortic Stenosis
Interventions
Device: Edwards SAPIEN Transcatheter Heart Valve
Other: medical management and/or balloon aortic valvuloplasty
Device: Surgical Valve Replacement
Registration Number
NCT00530894
Lead Sponsor
Edwards Lifesciences
Brief Summary

The purpose of this study is to determine the safety and effectiveness of the device and delivery systems (transfemoral and transapical) in high risk, symptomatic patients with severe aortic stenosis.

Detailed Description

Subjects will undergo a physical exam and screening tests will be performed to determine if they are either A) a patient with a high surgical risk or B) not a candidate for surgery. They will then be randomized (like the flip of a coin) to have the investigational device implanted or to receive the current surgical or medical management available.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1057
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Edwards SAPIEN Transcatheter Heart ValveCohort A: Sapien Valve
3Edwards SAPIEN Transcatheter Heart ValveCohort B: Sapien Valve
4medical management and/or balloon aortic valvuloplastyCohort B: Medical therapy
2Surgical Valve ReplacementCohort A: other surgical valve
Primary Outcome Measures
NameTimeMethod
Death1 Year

Death from any cause.

Composite of Death and Recurrence Hospitalization.duration of study

Death from any cause or repeat hospitalization after intervention.

Secondary Outcome Measures
NameTimeMethod
Functional Change of NYHABaseline to 1 year

NYHA classification change from baseline to 1 year visit. NYHA provides a way of classifying the extent of heart failure. New York Heart Association (NYHA) is a functional classification of heart failure based on how much a patient is limited during physical activity. The rating ranges from I - IV, with the lowest (I) as no limitations and the highest (IV) unable to carry on any physical activity without discomfort.

Number of Participants With Major Adverse Cardiac and Cerebro-vascular Events (MACCE)1 year

Number of participants with MACCE definition includes death, myocardial infarction (MI), stroke and renal failure

Total Hospital Days From the Index Procedure1 year

Total hospital days from the index procedure or randomization into control arm to one year post procedure or randomization.

Change in Quality of Life (QOL) From Baseline to 1 YearBaseline and 1 Year

The QOL questionnaire consisted of: Kansas City Cardiomyopathy (KCCQ), The Medical Outcomes Study Short-Form 12 (SF-12) - physical and metal states.

KCCQ scores are on a range of 0-100, in which 100 reflects the best health status and 0 reflects the worst health status.

SF-12 questionnaire was used in which 100 reflects the best health status and 0 reflects the worst health status.

Trial Locations

Locations (26)

Scripps Memorial Hospital/Scripps Green Hospital

🇺🇸

La Jolla, California, United States

Intermountain Medical Center

🇺🇸

Murray, Utah, United States

Heart Center Leipzig

🇩🇪

Leipzig, Germany

Laval Hospital

🇨🇦

Quebec, Canada

Washington Hospital Center

🇺🇸

Washington, D.C., District of Columbia, United States

New York Presbyterian Hospital - Cornell

🇺🇸

New York, New York, United States

Columbia University Medical Center

🇺🇸

New York, New York, United States

Vancouver St. Paul's

🇨🇦

Vancouver, British Columbia, Canada

University of Virginia

🇺🇸

Charlottesville, Virginia, United States

Stanford University Medical Center

🇺🇸

Stanford, California, United States

Barnes-Jewish/Washington University

🇺🇸

Saint Louis, Missouri, United States

Mayo Clinic-Saint Marys Hospital

🇺🇸

Rochester, Minnesota, United States

St. Luke's Hospital of Kansas City

🇺🇸

Kansas City, Missouri, United States

The Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Medical City Dallas

🇺🇸

Dallas, Texas, United States

University of Washington

🇺🇸

Seattle, Washington, United States

Cedars Sinai Medical Center

🇺🇸

Los Angeles, California, United States

University of Miami

🇺🇸

Miami, Florida, United States

Emory University Hospital

🇺🇸

Atlanta, Georgia, United States

Northwestern University

🇺🇸

Chicago, Illinois, United States

NorthShore University HealthSystem

🇺🇸

Evanston, Illinois, United States

Ochsner Clinic

🇺🇸

New Orleans, Louisiana, United States

Boston Mass General

🇺🇸

Boston, Massachusetts, United States

Brigham and Women's

🇺🇸

Boston, Massachusetts, United States

Toronto General Hospital

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath